Boston Scientific Corporation (BSX) Presents at Leerink Partners Global Healthcare Brokers Conference (Transcript)

In that, you've got a $9 billion growth challenged CRM market, where you have a, probably the fastest-growing segment in cardiovascular medicine, is the EP market at probably $5 billion at the end ...

from crm - BingNews https://ift.tt/2C0xhVP
March 01, 2019 at 03:40PM